pharmaphorum

JANUARY 30, 2022

2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top life science hubs and apparently shrugging off the effects of the pandemic and Brexit. “History has handed the UK two world-leading sectors: life sciences and finance.

Life Science 98

Life Science Allergies DNA Licensing 98

XTalks

SEPTEMBER 28, 2023

Related: Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate Bayer’s new over-the-counter (OTC) cold, flu and allergy med Astepro not only emerged as the most viewed new pharma TV ad in the first half of the year, but also topped iSpot.tv’s list of all new brand ads with 7.4

Drugs 105

Drugs Allergies Branding FDA Approval 105

XTalks

AUGUST 12, 2024

Related: Asthma Drug Xolair Wins FDA Approval as First Treatment for Multiple Food Allergies “Today’s approval provides the first epinephrine product for the treatment of anaphylaxis that is not administered by injection. The availability of epinephrine nasal spray may reduce barriers to rapid treatment of anaphylaxis.

FDA Approval 105

FDA Approval Allergies Production Drugs 105

XTalks

APRIL 21, 2023

.” Cerner Enviza is a healthcare company headquartered in New York that specializes in life sciences data analysis and research. John Snow Labs is an American AI and NLP leader providing software, models and data consulting services for healthcare and life sciences industries.

Life Science 98

Life Science Allergies Drugs FDA Approval 98

XTalks

NOVEMBER 5, 2024

Its lead candidate, PL-14, targets nasal allergies and is scheduled for US Food and Drug Administration (FDA) submission via the 510(k) pathway, with preclinical trials expected to start in the second quarter of 2025 and pivotal trials by the end of 2025.

Drug Delivery 111

Drug Delivery Drugs Immune Response Allergies 111

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

DECEMBER 9, 2021

Johnson & Johnson Consumer Health focuses its external innovation efforts on Self Care, which consists of allergy, smoking cessation, pain, digestive health, and cough and cold; and Skin Health, which includes acne, sensitive skin, skin protection and aging skin support.

Allergies 105

Allergies Life Science Development Scientist 105

XTalks

SEPTEMBER 8, 2020

The funding for the trial is being supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA). AstraZeneca, a UK-based global pharmaceutical company, is leading the COVID-19 trial as a regulatory sponsor. Fauci, in a statement.

Manufacturing 83

Manufacturing Vaccination Vaccine Allergies 83

pharmaphorum

FEBRUARY 26, 2021

The cause of a rare disease can be varied, while most (72%) rare diseases are genetic, others can be the result of allergies or environmental concerns. Frequently disabling, a person’s quality of life is often affected by a loss of autonomy due to the chronic, progressive, degenerative, and frequently life-threatening aspects of the disease.

Research 117

Research Allergies Life Science Genetics 117

Velocity Clinical Research

OCTOBER 21, 2024

AI solutions designed specifically for the life sciences sector (rather than retrofitted from other industries) will require development by professionals who understand the unique challenges of our industry. For independent clinical trial sites, this is currently unattainable.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

XTalks

DECEMBER 20, 2022

Register for this free webinar to learn about drug testing in humanized mouse models in two therapeutic areas: food allergy and inflammatory bowel diseases (IBD). Live and On-Demand: Tuesday, January 24, 2023, at 11am EST (4pm GMT/UK). Why is Idacio a Cost-Effective Drug?

FDA Approval 98

FDA Approval Allergies Manufacturing Clinical Trials 98

The Pharma Data

JANUARY 12, 2021

13, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

The Pharma Data

AUGUST 30, 2021

“Aamir brings with him 25 years of experience developing innovative growth strategies, guiding mergers and acquisitions, and implementing high-impact programs to improve patients’ lives and transform performance for life science companies. He is the ideal leader to drive these efforts.”.

Allergies 52

Allergies Life Science Business Development Development 52

pharmaphorum

OCTOBER 4, 2022

She is the Co-Chair of the firm’s Health Care Practice Group, Co-Chair, Health Care & Life Sciences Sector – Medical Devices, and a core member of the firm’s life sciences and telemedicine industry teams. Kyle Faget is a partner and business lawyer with Foley & Lardner LLP.

Development 105

Development Regulation Cosmetics Life Science 105

XTalks

JANUARY 17, 2023

While albuterol rescue inhalers are currently used to alleviate symptoms of an asthma attack, they don’t treat underlying inflammation, explained Bradley Chipps, MD, former president of the American College of Allergy, Asthma and Immunology, in a statement issued by AstraZeneca.

FDA Approval 97

FDA Approval Containment Allergies Drugs 97

XTalks

AUGUST 13, 2020

Kaiser Permanente is also involved in the testing of Moderna’s investigational COVID-19 vaccine, which is being co-developed by the National Institute of Allergy and Infectious Diseases (NIAID). We know we can meaningfully contribute to helping determine whether this vaccine is effective in preventing COVID-19 disease.”.

Vaccination 89

Vaccination Vaccine Trials Clinical Trials 89

XTalks

MARCH 29, 2021

Related: Maternal Antibodies: How Allergies Can be Passed from Mothers to Children. Grantz, of the Division of Intramural Population Health Research at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development. Different racial demographics were represented in the cohort, in which 28.2 percent were Caucasian, 25.2

Genotype 98

Genotype Allergies Hormones Research 98

XTalks

SEPTEMBER 3, 2021

In its early days, it became best known for the discovery and development of the active ingredient in the allergy medication Allegra. The name Curia is based on a Latin word for purposeful assembly and aligns with Curia’s patient-inspired mission. AMRI was founded 30 years ago in Albany, New York.

Manufacturing 98

Manufacturing Branding Allergies Development 98

pharmaphorum

JANUARY 12, 2023

Furthermore, AZ and Avillion’s co-partnership – funded by Blackstone Life Sciences, Royalty Pharma, and Abingworth – has now expanded to include the BATURA study, a randomised phase 2b decentralised trial to further assess Airsupra’s role in reducing the risk of asthma exacerbations. Commenting on the approval, Bradley E.

FDA Approval 52

FDA Approval Allergies Trials Development 52

XTalks

APRIL 24, 2024

April marks not only the blossoming of spring and the onslaught of my allergies but also a pivotal moment for raising awareness and advocating for equitable healthcare access. National Minority Health Month, observed annually throughout April, serves to emphasize the recognition of the unique health challenges faced by minority communities.

Research 105

Research Allergies Clinical Trials Clinical Trials 105

XTalks

MAY 11, 2022

The Centers for Disease Control and Prevention (CDC) maintain that mRNA vaccines, such as those from Pfizer/BioNTech and Moderna, are the preferred shots for COVID-19.

Vaccination 98

Vaccination Vaccine Sales Allergies 98

XTalks

NOVEMBER 16, 2020

The study is being conducted in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH).

Vaccination 105

Vaccination Vaccine Trials Allergies 105

The Pharma Data

DECEMBER 30, 2020

Johnson & Johnson Buys Up Momenta – Life sciences giant J&J acquired Momenta Pharmaceuticals in a $6.5 Nestlé and Peanut Allergies – In August, Nestlé Health Science acquired the outstanding stakes of Aimmune for $2.6 Nestlé Health Science has a history of advancing nutritional therapies. Most Read Today.

Antibody 52

Antibody Allergies Branding Dermatology 52

XTalks

AUGUST 16, 2021

Speaking to ABC last week, National Institute of Allergy and Infectious Diseases (NIAID) chief Anthony Fauci said that the pending authorization (at the time) would “encompass a relatively small proportion of the population, around three percent or so,” and would include cancer and transplant patients.

Vaccination 104

Vaccination Vaccine Antibody Immune Response 104

XTalks

NOVEMBER 30, 2023

Supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Bill & Melinda Gates Foundation, the Phase I trial is underway to assess the safety, reactogenicity and immunogenicity of VIR-1388.

FDA Approval 111

FDA Approval Gene Therapy Clinical Trials Gene 111

XTalks

JANUARY 20, 2021

However, IBS patients do not have allergies to any given foods, nor any gastrointestinal conditions, such as celiac disease. Moreover, the response did not induce symptoms typical of a food allergy. Approximately 20 percent of people in the world experience some form of pain or discomfort after a meal.

Immune Response 52

Immune Response Research Allergies Protein 52

pharmaphorum

FEBRUARY 16, 2022

Will all the efforts to speed up market access and ensure that the UK remains attractive to the life sciences industry post-Brexit pay off in 2022? Life Sciences Vision set an ambitious agenda in 2021 with delivery ongoing in 2022. MHRA gave first Project Orbis approvals in 2021 followed by mixed success for access deals.

Marketing 52

Marketing Life Science Medicine Gene Therapy 52

pharmaphorum

SEPTEMBER 17, 2021

Other Gold winning client companies were Biotest AG, Edwards Life Sciences, Frontline.Live, Huntleigh, Galderma, GSK, Janssen Pharmaceutica NV, Norgine, Santen and Takeda UK. Allergy Test n Treat Service. Havas Life Medicom for Galderma. Havas Life Medicom for Novartis Gene Therapies. Allergy Test n Treat eTool.

Gene Therapy 52

Gene Therapy Gene Allergies Life Science 52

XTalks

NOVEMBER 6, 2020

Related: Red Meat Allergy Test Gets FDA Clearance. “We The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccination Vaccine 75

The Pharma Data

NOVEMBER 5, 2020

Jubilant Pharma Limited (JPL), a company incorporated under the laws of Singapore and a wholly-owned subsidiary of Jubilant Life Sciences Limited, is an integrated global Pharmaceutical company engaged in manufacturing and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile (..)

Marketing 40

Marketing Generic Pharmaceutical Contract Manufacturing Manufacturing 40

XTalks

MAY 16, 2023

By extracting essential details from medical records, including medical history, test results and allergies, ChatGPT can present doctors with a comprehensive overview of a patient’s health status.

Doctors 97

Doctors Doctor Allergies Compliance 97

XTalks

AUGUST 2, 2023

With Blackstone Life Sciences, up to €300 million (around $315 million USD) will be invested to accelerate pivotal studies and clinical development programs for formulating the subcutaneous delivery of the anti-CD38 antibody Sarclisa (isatuximab) for the treatment of multiple myeloma. 21) Merck KGaA By: Ayesha Rashid, Ph.D.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

OCTOBER 26, 2023

Some of the vaccines are already in clinical trials, including a universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health (NIH).

Vaccination 105

Vaccination Vaccine RNA Manufacturing 105

XTalks

MARCH 1, 2021

Perhaps the same approach taken by those with food allergies to avoid foods that might trigger a reaction could be applied to patients with dry eye, suggests Dr. Hom. Dry eye disease truly is a chronic condition for which there is no cure, so the operative word, at least for now, is management.

Sales 119

Sales Drugs Life Science Containment 119

The Pharma Data

AUGUST 7, 2020

We are committed to bringing these life-changing therapies to patients in need,” Lambert added. CluePoints provides clinical studies with risk management support package during Covid-19. These manufactured antibodies have been developed and manufactured by Eli Lilly and Company ’s Lilly Research Laboratories in a partnership with AbCellera.

Clinical Trials 52

Clinical Trials Clinical Trials Gene Trials 52

XTalks

DECEMBER 29, 2021

This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or reusable in less than ten years’ time.

Packaging 59

Packaging Packaging Production Allergies 59

XTalks

SEPTEMBER 16, 2024

KalVista will present further data from the KONFIDENT and KONFIDENT-S trials at the 2024 Annual Scientific Conference of the American College of Allergy, Asthma and Immunology Conference in Boston from October 24 to 28. The drug demonstrated a consistent safety and efficacy profile with KONFIDENT.

Protein 52

Protein Genetics Trials Allergies 52